Abeona Therapeutics Inc (ABEO)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

3333 LEE PARKWAY DALLAS, TX 75219

Chemex Pharmaceuticals Inc. focused on developing both novel low development risk product candidates and technologies with longer-term major product opportunities.
Access Pharmaceuticals is a biopharmaceutical company developing products for use in the treatment of cancer, the supportive care of cancer, and other disease states. As of Dec 31 2006, Co.'s key clinical development program for its drug candidate ProLindac? is in Phase II clinical testing. In addition, Co. is developing other drug delivery technologies including Cobalamin?-mediated oral drug delivery and targeted delivery. Together with its subsidiaries, Co. has proprietary patents or rights to three drug delivery technology platforms, including synthetic polymer targeted delivery, cobalamin-mediated delivery, and mucoadhesive liquid technology.

Data based on most recent fiscal year report
Market Cap654.92 Million Shares Outstanding46.78 Million Avg Volume1.149 Million
1-Yr BETA vs S&P TR Current Ratio25.06 Quick Ratio25.06
View SEC Filings from ABEO instead.
Q2 2019 All Institutions Hedge Funds 1
To trade ABEO now:
Filers who had this stock in their top 10: 1 0 (0.0%)
13F Filers holding this stock: 99 20 (2.07%)
Aggregate 13F shares on 06/30/2019: 28.925 Million 9.565 Million
Aggregate 13F shares on 03/31/2019: 31.272 Million 6.761 Million
Percent change: -7.50% 41.46%
Funds creating new positions: 23 10
Funds Adding to an existing position: 35 7
Funds closing out their position: 14 5
Funds reducing their position: 13 2
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding ABEO (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

ALVINO MARK

  • Director
0 2019-05-21 1

WIDER TODD

  • Director
0 2019-05-21 1

VAN DUYNE RICHARD B

  • Director
0 2019-05-21 2

BUONO STEFANO

  • Director
0 2019-05-21 2

HOWELL STEPHEN B.

  • Director
0 2019-05-21 2

ROUHANDEH STEVEN H EXECUTIVE CHAIRMAN

  • Officer
  • Director
  • 10% Owner
0 2019-04-09 1

MILLER TIMOTHY J SEE REMARKS

  • Officer
0 2019-04-09 1

SIFFERT JOAO MD CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
0 2019-04-09 3

SILVERSTEIN CHRISTINE BERNI CHIEF FINANCIAL OFFICER

  • Officer
0 2019-04-09 3

CARR EDWARD CHIEF ACCOUNTING OFFICER

  • Officer
0 2019-04-09 3

THIEL CARSTEN

  • Director
0 2018-08-31 0

LUCI DAVID P

  • Director
2,430 2018-08-20 0

THOMPSON STEPHEN B SR VP FINANCE

  • Officer
0 2017-12-14 0

JEFFREY B DAVIS COO

  • Officer
0 2017-12-14 0

AHN MARK J

  • Director
0 2016-12-13 0

ROUHANDEH STEVEN H

SCO CAPITAL PARTNERS LLC

BEACH CAPITAL LLC

  • Director
  • 10% Owner
37,121,279 2014-12-24 0

AYER CAPITAL MANAGEMENT, LP

AYER CAPITAL PARTNERS, LLC

ACM CAPITAL PARTNERS, LLC

VENKATESAN JAY

  • Director
  • 10% Owner
5,604,015 2013-12-31 0

NOWOTNIK DAVID P SR. VP R&D

  • Officer
0 2012-05-24 0

SCO CAPITAL PARTNERS L P

SCO CAPITAL PARTNERS LLC

ROUHANDEH STEVEN H

  • 10% Owner
23,421,976 2008-12-18 1

ORACLE INSTITUTIONAL PARTNERS L P

  • 10% Owner
40,165 2008-03-11 0

SCO CAPITAL PARTNERS LLC

ROUHANDEH STEVEN H

  • 10% Owner
No longer subject to file 2008-01-04 0

ORACLE INVESTMENT MANAGEMENT INC

  • 10% Owner
34,743 2007-11-09 0

ORACLE PARTNERS LP

  • 10% Owner
247,651 2007-11-09 0

FEINBERG LARRY N

ORACLE ASSOCIATES LLC

ORACLE PARTNERS LP

ORACLE INSTITUTIONAL PARTNERS L P

ORACLE INVESTMENT MANAGEMENT INC

  • 10% Owner
13,695,481 2005-02-01 0

ORACLE ASSOCIATES LLC

  • 10% Owner
900,400 2001-07-15 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5
No current insider transactions
Click here to report any possible errors with this stock listing.

Elevate your investments